Intellectual Property India Publishes Patent Application for Peptide Acids As A Glp1r Agonist And Antibody-Drug Conjugates Thereof

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617060420 A) filed by Regeneron Pharmaceuticals, Inc. on May 12, 2026, for Peptide Acids As A Glp1r Agonist And Antibody-Drug Conjugates Thereof.

Inventors include Han, Amy; Zheng, Xiang; Olson, William; Murphy, Andrew J.; Delfino, Frank; Okamoto, Haruka; Yanolatos, Jean; Cao, Huachuan; and Sleeman, Mark W..

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: Described herein are protein-drug conjugates and compositions thereof that are useful, for example, for targeting glucagon-like peptide 1 receptor (GLP1R). In certain embodiments, provided are peptidomimetic payloads and linker-payloads and...